| 标题 |
LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:R. Herbst; G. Lopes; D. Kowalski; K. Kasahara; Y. Wu; et al 出版日期:2019-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)